UCSF home page About UCSF UCSF Medical Center
UCSF home page | About UCSF | UCSF Medical Center

Skip to TransPortal content

Decrease the text sizeRestore original text sizeIncrease the text size Enlarge Text
Click to increase the text size. Restore Text
Click to restore original text size. Reduce Text
Click to decrease the text size.
Transporter Database banner  
Decrease the text size | Restore text size | Increase the text size
 Text Sizer image
Home About and More Information Transporter Data Index
Search:  
 

Betamipron

Substrate Information
Inhibitor Information
Clinical Drug-drug Interactions

In Vitro Substrates

No substrate information.


Back to top

In Vitro Inhibitors

* denotes drugs that can potentially be used for in vivo (clinical) studies of the designated transporter
Transporter Synonyms Inhibitor IC50 (μM) Ki (μM) Substrate used Cell System Reference
SLC22A6 OAT1 Betamipron 6 Adefovir CHO-OAT1 Mulato, 2000
ABCC2 MRP2, cMOAT Betamipron >133 Estradiol-17beta-glucuronide Sf9 cell membrane vesicles Morgan, 2013
ABCC3 MRP3 Betamipron >133 Estradiol-17beta-glucuronide Sf9 cell membrane vesicles Morgan, 2013
ABCC4 MRP4 Betamipron >133 Estradiol-17beta-glucuronide Sf9 cell membrane vesicles Morgan, 2013
SLC22A8 OAT3 Betamipron 48.3 Estrone sulfate S2-OAT3 Takeda, 2001
SLC22A6 OAT1 Betamipron 16.2 Para-aminohippurate CHO-OAT1 Ho, 2000
SLC22A6 OAT1 Betamipron 23.6 Para-aminohippurate S2-OAT1 Takeda, 2001
SLC22A11 OAT4 Betamipron 502 Prostaglandin F2-alpha S2-OAT4 Enomoto, 2002
ABCB11 BSEP Betamipron >133 Taurocholate Sf9 cell membrane vesicles Morgan, 2013

Back to top

Clinical Drug-Drug Interactions

No drug-drug interaction information.


Back to top

Contact us | Glossary

Blue banner